Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease

NCT05651958 | Completed

• 1 other identifier: REC/22/0351 Amina Muqaddas
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

It will be randomized controlled trial. The research will be conducted at Bahawal Victoria hospital Bahawalpur and civil hospital Bahawalpur. We take 60 patients (Epitool), Patients will be allocated randomly in two groups. Group A will get conventional medical treatment and Group B will get both conventional medical treatment and pranayama breathing exercise. Both gender of age group 30 to 55, Patient with diagnosed Chronic obstructive pulmonary disease ,Moderate to severe Chronic obstructive pulmonary disease with productive cough, Shortness of breathe and no surgical procedure performed will be included in this study. And patients of lung surgery, lung cancer, above 70 years age, with open wound, cardiovascular issues, and neurological issues will be excluded. Yoga exercise pranayama, 6 min walk test, IPAQ- quality of life and VSAQ-exercise capacity will be used as tools. Data will be analyzed on SPSS 21.

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Pranayama; COPD; Dyspnea; Exercise tolerance

Outcome Measures

Primary Outcomes (3)

• 6 min walk test.

  The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

  Six Weeks

• IPAQ- quality of life

  The International Physical Activity Questionnaire (IPAQ) will be used to evaluate the current physical activity level of the participants.

  Six Weeks

• VSAQ-exercise capacity

  The VSAQ, capturing patient-reported outcome measures, is an efficient and quantifiable measure of exercise capacity that can be readily employed in clinical services particularly where patients have normal to high exercise tolerance

  Six Weeks

Study Arms (2)

Pranayma Breathing Technique

EXPERIMENTAL

Pranayma Breathing Technique protocol includes 15 breaths in the morning and 15 breaths in evening for atleast weeks.

Other: Breathing Technique

Conventional Treatment

ACTIVE COMPARATOR

Long-acting beta-2 agonist, nebulizers and long acting anti-mucosic drugs.

Other: Nebulizer

Interventions

Nebulizer OTHER

Active Comparator: Nebulization every 3 days with the other medicine to the active comparator.

Conventional Treatment

Breathing Technique OTHER

15 repeatations of Breathing in morning and evening

Pranayma Breathing Technique

Eligibility Criteria

• Age: 30 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Both gender of age group 30 to 55
• Patient with diagnosed COPD.
• Moderate to severe COPD.
• Patient with productive cough and SOB.
• No surgical procedure perform.

You may not qualify if:

• Patient of lung surgery
• Lung cancer patient
• Patient above 70 years age.
• Patient with open wound.
• Patient with cardiovascular issues

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Bahawal Victoria Hospital and Civil Hospital

Chak Four Hundred Fifty-four, Punjab Province, 63100, Pakistan

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Dyspnea

Interventions

Nebulizers and Vaporizers

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

• madiha younas, MS

  riphah internationl university

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 6, 2022
• First Posted: December 15, 2022
• Study Start: February 1, 2022
• Primary Completion: January 31, 2023
• Study Completion: January 31, 2023
• Last Updated: February 21, 2023

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)